Search

Your search keyword '"Bonsall D."' showing total 100 results

Search Constraints

Start Over You searched for: Author "Bonsall D." Remove constraint Author: "Bonsall D." Language english Remove constraint Language: english
100 results on '"Bonsall D."'

Search Results

1. Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse

3. SARS-CoV-2 evolution during treatment of chronic infection

4. Genomic reconstruction of the SARS-CoV-2 epidemic in England

5. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

6. Virological and serological characterization of critically ill patients with COVID-19 in the UK: Interactions of viral load, antibody status and B.1.1.7 variant infection

8. Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

9. Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants

11. PANGEA-HIV 2: Phylogenetics and networks for generalised epidemics in Africa

12. Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis

13. Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis

14. Characterisation of hepatitis C virus recombination in Cameroon using non-specific next generation sequencing

15. Comparison of next generation sequencing technologies for the comprehensive assessment of full-length hepatitis C viral genomes

20. THU-253 - Comparison of next Generation Sequencing Technologies for the Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes

22. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

24. Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection

25. A putative hepatitis B virus sequence motif associated with hepatocellular carcinoma in South African adults.

26. Population dynamics of HIV drug resistance during treatment scale-up in Uganda: a population-based longitudinal study.

27. Castanet: a pipeline for rapid analysis of targeted multi-pathogen genomic data.

28. Intra- and inter-subtype HIV diversity between 1994 and 2018 in southern Uganda: a longitudinal population-based study.

29. HIV transmission dynamics and population-wide drug resistance in rural South Africa.

30. Age and gender profiles of HIV infection burden and viraemia: novel metrics for HIV epidemic control in African populations with high antiretroviral therapy coverage.

31. Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus.

32. Increasing intra- and inter-subtype HIV diversity despite declining HIV incidence in Uganda.

33. Prevalence of persistent SARS-CoV-2 in a large community surveillance study.

34. Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda.

35. Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study.

36. Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes.

37. Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory.

38. HIV transmission dynamics and population-wide drug resistance in rural South Africa.

39. Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda.

40. Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey.

41. Correction: Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias.

42. Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias.

43. Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort.

44. The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA.

45. Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort.

46. Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.

47. A highly virulent variant of HIV-1 circulating in the Netherlands.

48. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.

50. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.

Catalog

Books, media, physical & digital resources